AAAAAA

   
Results: 1-15 |
Results: 15
CASE-CONTROL, HAPLOTYPE RELATIVE RISK AND TRANSMISSION DISEQUILIBRIUMANALYSIS OF A DOPAMINE D2 RECEPTOR FUNCTIONAL PROMOTER POLYMORPHISM IN SCHIZOPHRENIA
Authors: LI T ARRANZ M AITCHISON KJ BRYANT C LIU XH KERWIN RW MURRAY R SHAM P COLLIER DA
Citation: T. Li et al., CASE-CONTROL, HAPLOTYPE RELATIVE RISK AND TRANSMISSION DISEQUILIBRIUMANALYSIS OF A DOPAMINE D2 RECEPTOR FUNCTIONAL PROMOTER POLYMORPHISM IN SCHIZOPHRENIA, Schizophrenia research, 32(2), 1998, pp. 87-92
APOLIPOPROTEIN-E - DEPRESSIVE-ILLNESS, DEPRESSIVE SYMPTOMS, AND ALZHEIMERS-DISEASE
Authors: HOLMES C RUSS C KIROV G AITCHISON KJ POWELL JF COLLIER DA LOVESTONE S
Citation: C. Holmes et al., APOLIPOPROTEIN-E - DEPRESSIVE-ILLNESS, DEPRESSIVE SYMPTOMS, AND ALZHEIMERS-DISEASE, Biological psychiatry, 43(3), 1998, pp. 159-164
PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS
Authors: AITCHISON KJ MUNRO J WRIGHT P CHAPMAN S COLLIER DA KERWIN RW
Citation: Kj. Aitchison et al., PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS, Schizophrenia research, 24(1-2), 1997, pp. 89-89
ALLELIC VARIATION OF THE 5-HT2C RECEPTOR IN PSYCHOSIS
Authors: SODHI MS KIROV G AITCHISON KJ ARRANZ MJ COLLIER DA KERWIN RW
Citation: Ms. Sodhi et al., ALLELIC VARIATION OF THE 5-HT2C RECEPTOR IN PSYCHOSIS, Schizophrenia research, 24(1-2), 1997, pp. 90-91
PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS
Authors: AITCHISON KJ MUNRO J WRIGHT P CHAPMAN S MAKOFF AJ COLLIER DA KERWIN RW
Citation: Kj. Aitchison et al., PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS, The FASEB journal, 11(9), 1997, pp. 322-322
PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS
Authors: AITCHISON KJ MUNRO J WRIGHT P CHAPMAN S SODHI MS MAKOFF AJ COLLIER DA KERWIN RW
Citation: Kj. Aitchison et al., PHARMACOGENETIC FACTORS IN TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CYP2D6 VARIANTS, American journal of medical genetics, 74(6), 1997, pp. 633-634
COST-EFFECTIVENESS OF CLOZAPINE - A UK CLINIC-BASED STUDY
Authors: AITCHISON KJ KERWIN RW
Citation: Kj. Aitchison et Rw. Kerwin, COST-EFFECTIVENESS OF CLOZAPINE - A UK CLINIC-BASED STUDY, British Journal of Psychiatry, 171, 1997, pp. 125-130
COST-EFFECTIVENESS OF CLOZAPINE
Authors: KERWIN RW AITCHISON KJ
Citation: Rw. Kerwin et Kj. Aitchison, COST-EFFECTIVENESS OF CLOZAPINE, British Journal of Psychiatry, 171, 1997, pp. 584-584
NO EVIDENCE FOR AN ASSOCIATION OF AFFECTIVE-DISORDERS WITH HIGH-ACTIVITY OR LOW-ACTIVITY ALLELE OF CATECHOL-O-METHYLTRANSFERASE GENE
Authors: KUNUGI H VALLADA HP HODA F KIROV G GILL R AITCHISON KJ BALL D ARRANZ MJ MURRAY RM COLLIER DA
Citation: H. Kunugi et al., NO EVIDENCE FOR AN ASSOCIATION OF AFFECTIVE-DISORDERS WITH HIGH-ACTIVITY OR LOW-ACTIVITY ALLELE OF CATECHOL-O-METHYLTRANSFERASE GENE, Biological psychiatry, 42(4), 1997, pp. 282-285
THE SEROTONIN TRANSPORTER IS A POTENTIAL SUSCEPTIBILITY FACTOR FOR BIPOLAR AFFECTIVE-DISORDER
Authors: COLLIER DA ARRANZ MJ SHAM P BATTERSBY S VALLADA H GILL P AITCHISON KJ SODHI M LI T ROBERTS GW SMITH B MORTON J MURRAY RM SMITH D KIROV G
Citation: Da. Collier et al., THE SEROTONIN TRANSPORTER IS A POTENTIAL SUSCEPTIBILITY FACTOR FOR BIPOLAR AFFECTIVE-DISORDER, NeuroReport, 7(10), 1996, pp. 1675-1679
ASSOCIATION BETWEEN PSYCHOSES AND ALLELIC VARIATION IN THE 5-HT2C RECEPTOR GENE
Authors: SODHI MS KIROV G ARRANZ MJ BALL DM AITCHISON KJ KERWIN RW COLLIER DA
Citation: Ms. Sodhi et al., ASSOCIATION BETWEEN PSYCHOSES AND ALLELIC VARIATION IN THE 5-HT2C RECEPTOR GENE, Schizophrenia research, 18(2-3), 1996, pp. 2-2
NEUROLEPTIC SENSITIVITY AND ENZYME DEFICIENCY IN 2 SCHIZOPHRENIC BROTHERS - A CASE-REPORT
Authors: AITCHISON KJ PATEL M TAYLOR M MURRAY RM ARRANZ MJ COLLIER DA KERWIN RW
Citation: Kj. Aitchison et al., NEUROLEPTIC SENSITIVITY AND ENZYME DEFICIENCY IN 2 SCHIZOPHRENIC BROTHERS - A CASE-REPORT, Schizophrenia research, 18(2-3), 1996, pp. 152-152
NO ASSOCIATION BETWEEN PARKINSONS-DISEASE AND LOW-ACTIVITY ALLELES OFCATECHOL O-METHYLTRANSFERASE
Authors: HODA F NICHOLL D BENNETT P ARRANZ M AITCHISON KJ ALCHALABI A KUNUGI H VALLADA H LEIGH PN CHAUDHURI KR COLLIER DA
Citation: F. Hoda et al., NO ASSOCIATION BETWEEN PARKINSONS-DISEASE AND LOW-ACTIVITY ALLELES OFCATECHOL O-METHYLTRANSFERASE, Biochemical and biophysical research communications, 228(3), 1996, pp. 780-784
ANALYSES OF CLOZAPINE RESPONSE AND THE 5-HT2 GENE
Authors: ARRANZ MJ AITCHISON KJ KERWIN R COLLIER DA
Citation: Mj. Arranz et al., ANALYSES OF CLOZAPINE RESPONSE AND THE 5-HT2 GENE, Schizophrenia research, 15(1-2), 1995, pp. 35-35
THE COSTS AND BENEFITS OF CLOZAPINE THERAPY IN THE UK
Authors: AITCHISON KJ KERWIN RW
Citation: Kj. Aitchison et Rw. Kerwin, THE COSTS AND BENEFITS OF CLOZAPINE THERAPY IN THE UK, Schizophrenia research, 15(1-2), 1995, pp. 141-141
Risultati: 1-15 |